芳香疗法吸入对化疗引起的恶心和吐的影响:对照试验
Debbie Anglade1, Caterine Diaz2, Roberto Roman Laporte3
1School of Nursing & Health Studies, University of Miami, Coral Gables, FL, United States.
概括
芳香疗法吸入显著减少化疗诱导的恶心和吐 (CINV) 以及癌症患者需要抗药物的需要. 这种补充疗法为管理CINV症状提供了潜在的好处.
科学领域:
- 在瘤学瘤学.
- 补充和替代医学 补充和替代医学
- 症状管理 症状管理
背景情况:
- 化疗诱导的恶心和吐 (CINV) 是接受治疗的癌症患者常见和令人痛苦的副作用.
- 有效的CINV管理对于维持治疗坚持和改善患者的生活质量至关重要.
- 目前的抗治疗方案并不能完全控制所有患者的CINV,因此需要探索补充疗法.
研究的目的:
- 评估芳香疗法吸入的疗效,作为减少化疗引起的恶心和吐 (CINV) 的干预措施.
- 评估芳香疗法对接受中度至高发性化疗 (HEC) 的患者使用抗发药物的影响.
主要方法:
- 进行了一项双臂随机临床试验,其中100名参与者接受了HEC.
- 干预组除了接受标准的抗治疗外,还接受了芳香疗法吸入治疗.
- 对照组仅接受医生处方的抗治疗.
主要成果:
- 与对照组相比,芳香疗法干预组的CINV和抗药物使用显著减少.
- 干预组在所有研究访问中报告的反药物使用情况要少得多.
- 与干预组相比,对照组使用了更多的非药物干预措施,如茶和食物.
结论:
- 芳香疗法吸入显示出作为一种有益的补充疗法的潜力,用于管理CINV.
- 这种非药理学方法可能有助于减轻接受化疗的癌症患者的恶心和吐负担.
- 进一步的研究支持将芳香疗法整合到患有CINV的癌症患者的支持性护理中.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
798
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
798
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
708
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
708
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
923
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
923
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
641
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
641
Pathophysiology of Vomiting
3.2K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.2K
Inhaled Medications
829
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
829


